SCHEMBL1190832

SCHEMBL1190832

[CH2]CC=CCC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1190830 1.00
SCHEMBL109550 0.83 TSHR (0.33)
SCHEMBL109549 0.83 TSHR (0.33)
SCHEMBL17764763 0.83 TSHR (0.33)
SCHEMBL4455007 0.78
SCHEMBL4455005 0.78
SCHEMBL2118191 0.77
SCHEMBL2118194 0.77
SCHEMBL2121145 0.75
SCHEMBL2121141 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888338-B2 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2011-02-15 US claimed
US-20060178350-A1 7-(2-Cyclohexylidene-ethylidene)-spiro[4.5]decanes UNIVERSITEIT GENT (BE) 2006-08-10 US claimed
WO-2006060884-A1 7-(2-CYCLOHEXYLIDENE-ETHYLIDENE)-SPIRO[4.5]DECANES K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2006-06-15 WO claimed
CN-118119588-A Precursors for phenolic aromatic compounds 奇华顿股份有限公司 2024-05-31 CN disclosed
US-20230250218-A1 URETHANE COMPOSITION NITTO KASEI CO., LTD. (JP) 2023-08-10 US disclosed
EP-4198068-A1 URETHANE COMPOSITION Nitto Kasei Co., Ltd. (JP) 2023-06-21 EP disclosed
WO-2023083576-A1 PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS GIVAUDAN SA (CH) 2023-05-19 WO disclosed
WO-2023065200-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2023-04-27 WO disclosed
CN-116018365-A Carbamate composition 日东化成株式会社 2023-04-25 CN disclosed
EP-2444401-B1 NOVEL IMIDAZOPYRIDINE COMPOUND ONO PHARMACEUTICAL CO (JP) 2014-09-03 EP disclosed
CN-101720317-B Process for producing difluoromethyl-substituted pyrazole compound BASF SE 2014-07-09 CN disclosed
EP-0761225-A1 PHARMACEUTICAL COMPOSITION FOR TREATING PERIPHERAL CIRCULATION DISORDER TEIJIN LIMITED (JP) 1997-03-12 EP disclosed
US-5610182-A ADMINISTERING AN ISOCARBACYCLIN OF SPECIFIC STRUCTURE IN THE FORM OF A FAT EMULSION TEIJIN, LIMITED (JP) 1997-03-11 US disclosed
US-5530027-A PROSTAGLANDINS AND/OR ITS OPTICAL ISOMER FOR SKIN DISORDERS TEIJIN LIMITED (JP) 1996-06-25 US disclosed
CN-1102039-A External skin therapeutic agent composition containing isocarbacyclin as active ingredient TEIJIN LTD (JP) 1995-04-26 CN disclosed
CN-1102038-A External skin therapeutic agent composition containing prostacyclin as active ingredient TEIJIN LTD (JP) 1995-04-26 CN disclosed
CN-1101781-A Pharmaceutical composition for treating cerebral thrombosis TEIJIN LTD (JP) 1995-04-19 CN disclosed
EP-0638312-A1 DERMATOLOGIC PREPARATION COMPOSITION CONTAINING ISOCARBACYCLIN AS ACTIVE INGREDIENT TEIJIN LIMITED (JP) 1995-02-15 EP disclosed
EP-0634172-A1 DERMATOLOGIC PREPARATION COMPOSITION CONTAINING PROSTACYCLIN AS ACTIVE INGREDIENT TEIJIN LIMITED (JP) 1995-01-18 EP disclosed
EP-0634171-A1 PHARMACEUTICAL COMPOSITION FOR TREATING CEREBRAL THROMBOSIS TEIJIN LIMITED (JP) 1995-01-18 EP disclosed